Signs and Symptoms of Measles

Measles is a contagious viral infection with potentially severe public health consequences.In this page, we're addressing the signs and symptoms of measles with information useful for everyday individuals and physicians alike. We will also address other related ramifications which include clinical information and ways to prevent the spread of measles in 2024.

This article aims to create a good level of awareness among patients and physicians alike regarding vaccination, early symptom recognition, and quick medical attention. Reportedly, measles killed 136,000 people worldwide in 2022 as per the World Health Organization (WHO), which highlights its fatal capabilities.

Physicians will benefit from the most current diagnostic and treatment options, as well as an improved understanding of how to manage complications that arise in response to measles. Measles — one of the most infectious diseases in existence, with an estimated reproductive number of 12 to 18—necessitates speedy identification and efficient case isolation on account of the ease and speed by which at their disposal it can trigger outbreaks.

The piece also confronts the roadblocks of vaccine hesitancy and emphasizes how provider advocacy for vaccination is essential. The article aims to make more people understand something about the seriousness of the virus and the necessity for vaccination so that they will take proactive actions to avoid catching or spreading a preventable but sometimes fatal disease.

Measles is an extremely contagious viral infection caused by the measles virus, a part of the Morbillivirus circle. Measles has been a leading cause of morbidity and mortality throughout history, particularly, in the case of children.

Image credit: Osmosis

Worldwide, before the measles vaccine was licensed in 1963, measles caused an estimated 2.6 million deaths. It has a rapid rate of transmission and can lead to severe complications.

Measles is a pertinent public health concern globally even with international immunization campaigns. With less than a month to the point when WHO announced some months after that, over 9 million cases and about 128,000 deaths in all of these regions had died as a result! Some of the spike in cases is caused by vaccine hesitancy

The measles virus is an RNA virus of the Paramyxoviridae family. It is spread when droplets from an infected cough or sneeze enter a healthy person’s respiratory system. It is highly infectious as the virus can last up to 2 hours in the air or on surfaces later being picked through by another person. The basic reproduction number, or R0 of measles is 12-18 so that every infected person can infect up to 18 others on average in a susceptible population.

After being introduced into the upper respiratory tract, it replicates in ciliated epithelial cells and rapidly disseminates to regional lymphatic tissue with subsequent systemic infection. The virus then spreads to multiple organs including the skin where it brings about a rash. Incubation Period: 7 to 14 days on average

Image credit: Commwellhealth

Measles slowly has distinct stages with unique symptoms. Early recognition of these symptoms is important to quickly rehydrate, avoid serious complications, and prevent outbreaks. This section outlines the early and progressive symptoms of measles, as well as severe and atypical presentations—vital information for both patients and clinicians.

Measles has an incubation period of 7-18 days (most often 10-12) followed by the usual symptoms which last two to six days. This first phase, known as the prodromal stage, can present a number of symptoms that closely relate to those common with other viral infections and without proper vigilance, it could be easily mistaken for something else.

The presence of cough, coryza, and conjunctivitis (the 3 Cs) in addition to fever should raise immediate suspicion for measles particularly if the patient is unvaccinated or comes from an area with recent outbreaks.

After the first symptoms of measles, others will develop that are often symptomatic of infection 3-5 days after the onset. This marked the onset of the exanthem phase, in which typically intolerance measles features appear after the prodromal stage. Symptom include:

Most measles cases show features as described above along a typical course, but in some patients with complications or when affecting more vulnerable populations the clinical presentation can range from severe to rare. Life-threatening complications are involved in these presentations.

Identifying these symptoms early and seeking immediate medical help can lower the risk of catastrophic results in patients. A comprehensive understanding of the nature and progression of this highly infectious disease, including possible complications, is indeed necessary for clinicians to manage it successfully while minimizing its potential spread. The result again underlines that through vaccination measles is the most effective tool to prevent infection.

In severe cases, including those that occur in healthy people, measles can also cause complications. Most cases of otitis media, or ear infection—which is most common in children—are reported with up to 10% measles cases. If it is not treated, this infection can cause hearing loss. It also results in the spread of infection to the respiratory tract, leading to bronchitis and laryngitis. These tend to be symptoms of a persistent cough, or shortness of breath resulting in medical intervention.

These complications can be as severe as encephalitis, pneumonia, or even death. Encephalitis, which is inflammation of the brain tissue that could lead to permanent neurological damage or death happens in about 1 per 1000 cases. Pneumonia, responsible for around 60% of deaths occurring during measles alone is the most common cause of death.

Image credit: Ourworldindata

In an overwhelming infection of the cornea, society will also become blind, especially in our children who are malnourished and Vitamin A deficient. Globally, measles killed 128,000 people in 2021—mostly those who were not vaccinated.

Advanced risk of developing severe complications include malnutrition, in particular vitamin A deficiency and immuno-suppression allowing the disease process or progression (often severe). Babies, pregnant women and people with weakened immune systems e.g. from having HIV are more at risk. Living under congested conditions or in low-coverage vaccination areas may increase the risk of severe complications as well.

Measles is also known to cause Subacute sclerosing panencephalitis (SSPE), a pernicious, fatal, and incurable disease of the central nervous system that could develop years after infection. SSPE strikes about 1 in every 10,000 cases of measles and is equally fatal.

In addition, measles gives rise to immune amnesia—effectively a high fever of unknown origin—where the virus wipes out cellular immunity memories from all past infections which means that recovered individuals are more susceptible to other diseases over several years following recovery. This makes vaccination vital for more than just preventing measles. It also helps stop the spread of future infections.

The clinical diagnosis of measles is made by recognizing the signs and symptoms typical for this illness. Measles usually causes high fever, coughing, coryza, and conjunctivitis followed by Koplik spots in the buccal mucosa. They are pathognomonic for measles and typically appear 1–2 days before a widespread maculopapular rash starting on the face that spreads to other parts of the body.

The rash is another important diagnostic criterion, usually for about one week before disappearing spontaneously. Clinical diagnosis, however, can be difficult — even in areas where measles is rare or if a person has only received one of the two required vaccinations and thus they may have milder symptoms that do not match those listed above. This is very important for differential diagnosis in the exclusion of other diseases with a similar presentation.

Laboratory confirmation of clinical suspicion is important. Most frequently, laboratory diagnosis is based on serological testing. The presence of measles-specific IgM antibodies in a blood sample indicates either a recent primary infection or prior immunization whereas these variants usually follow the appearance and continue to be detectable until approximately 6 weeks after rash onset.

The presence of IgG antibodies indicates previous infection or vaccination. Results show a fourfold increase in the levels of IgG between acute- and convalescent-phase samples that can also confirm an ongoing or recent infection.

Another valuable diagnostic test for measles is Polymerase Chain Reaction (PCR) testing. It is highly specific (greater than 97%) and very sensitive, in the detection of rather small amounts even before the patient makes antibodies to fight it off. PCR is especially valuable in outbreak Article settings, or when a fast analysis of measles must be made. It mostly serves to genotype the virus, a critical aspect of identifying outbreaks at their origins and tracing how they disseminate.

Laboratory tests are absolute and definitive for the diagnosis of measles, however, more cases can be diagnosed using imaging in case there is a complication. If pneumonia is suspected, a chest X-ray should be done. The x-ray may demonstrate bilateral infiltrates consistent with either viral pneumonia or secondary bacterial pneumonia with variations in each case requiring prompt and chosen intervention.

Other imaging studies are usually not needed unless symptoms are severe or atypical for osteoarthritis. Neuroimaging (e.g., MRI, CT scan) may be necessary for encephalitis suspected based on symptoms like a severe headache or seizures that are not as expected from a simple neurological examination, in patients with altered mental status. These aids assist in the evaluation of brain involvement and direct further treatment.

Treatment of measles is multi-faceted and includes supportive care, antiviral therapeutics and the treatment for resultant complications Management of patients with more severe manifestations is vital to avert potentially life-threatening complications, particularly in high-risk populations.

Treatment for measles is largely supportive-based and aimed at symptom relief, as well as prevention of complications. Make sure they are drinking as measles causes a high fever and is associated with diarrhea which can lead to dehydration. Drinking enough fluids also may help to preserve electrolyte balance and overall recovery.

Again fever management also plays a very important role in care. Forms of an antipyretic (acetaminophen or ibuprofen) are often used to lower fever and make clients feel more comfortable. In contrast, aspirin is not recommended for children until the age of 16 years because of a risk (albeit small) that they could develop Reye's syndrome.

Measles vaccination is of course the single most effective measure to reduce morbidity and mortality due to measles that has been known for many years. Children diagnosed with measles should receive two doses of vitamin A.

WHO recommends high-dose supplementation through carefully calculated vitamin A to all children with measles, especially where there is a proven deficiency. This supplementation reduces the severity of complications, including pneumonia and blindness by improving immune function and supporting the regeneration of damaged epithelial tissue from the virus. For very severe cases, it can reduce the risk of death by half.

Currently, there is no licensed antiviral drug for the treatment of measles; care options are mainly limited to supportive therapy. Some experimental treatments with antiviral agents are showing signs of effectiveness.

Ribavirin is a broad-spectrum antiviral drug that has been used to treat severe measles, especially in immunocompromised patients. While there are individual studies supporting that ribavirin within this time frame could decrease symptoms' intensity and duration, its use is not established due to a lack of firm evidence in the literature as well as potential side effects.

Researchers are also studying potentially newly added immunomodulatory agents that may cause your immune system to respond more aggressively against the virus. Yet, such treatments continue to be investigational, and additional research is required before promotion for routine use.

The prevention of complications is an essential component in the treatment of measles especially among those who are serious or life-threatening. Pneumonia accounts for most measles-related deaths, and it should be treated with antibiotics on time. Often there is bacterial superinfection of Measles pneumonia, so antibiotics may be given for that. When cases are more severe, oxygen therapy or mechanical ventilation in the hospital may be required.

A more serious complication is encephalitis, which requires emergency medical treatment. Treatment is usually supportive and hospitalized with oral or parenteral hydration, it may be complicated in some cases by the occurrence of encephalitis for which there are no effective antivirals.

Measles is one of the most contagious diseases there are and infection by this virus leads to severe complications, which makes it a disease that public health should try to prevent. Measles is underpinned by a strong vaccine; however, firmly supported public health measures and post-exposure prophylaxis will enhance its containment. The performance of all these interventions ensures adequate control of measles which is necessary to protect high-risk groups.

Measles is best prevented by a highly effective MMR (measles, mumps, and rubella) vaccine. The MMR is a two-dose vaccine. The first dose is at 12-15 months and the second is at 4-6 years. This two-dose series is important to ensure durable immunity. The MMR vaccines are strongly effective; a single dose is about 93 percent effective at preventing measles, and two doses provide more than 97% protection.

Vaccination and public health control measures prevent regions of spread, outbreaks, or re-introductions. When the U.S. experienced a resurgence of measles in 2019, targeted vaccination campaigns were used to help bring it under control in those communities that had low immunization coverage and promotional activities helped increase vaccine uptake further preventing additional infections.

Another important aspect of measles prevention is travel advice and recommendations. Although vaccination is essential for all international travelers, it should be a priority for those journeying to areas with widespread ongoing measles transmission.

Public health interventions also will entail educational programs to ward off vaccine resistance and disinformation. This creates pseudo-stigma whereby since an individual(s) think the vaccine is either dangerous or unnecessary, their vaccination rates drop significantly and so can set situations where outbreaks are more likely to occur.

A person who was exposed to measles but is not yet vaccinated or at high risk for severe disease can be protected from the onset of illness by post-exposure prophylaxis. One of them is immunoglobulin (IG) therapy
Another mechanism of this kind is the IgG (Immunoglobulin – IG) therapy. It contains antibodies that can be administered within 6 days post-exposure to prevent and/or mitigate disease. IG is particularly useful in infants, nonimmune pregnant women, and immunocompromised persons who cannot receive MMR vaccine.

An early diagnosis and appropriate treatment are crucial to decrease the morbidity associated with it. The MMR vaccine in particular would be dangerous to avoid; it is 97% effective at preventing measles and herd immunity depends on practically everyone getting their shots.

Clinicians must promote vaccination and public health interventions to prevent outbreaks, especially in low-coverage communities. Those who can—patients and parents—should ensure vaccinations are current in order to prevent the spread of these diseases, both to themselves as well as to others they come across with. Working together, we can stop measles and maintain public health.

CDC issues measles alert urging parents to get children vaccinated. (2024, March 19). [Video]. NBC News.

Fappani, C., Gori, M., Canuti, M., Terraneo, M., Colzani, D., Tanzi, E., Amendola, A., & Bianchi, S. (2022). Breakthrough Infections: A Challenge towards Measles Elimination? Microorganisms, 10(8), 1567.

Measles, Mumps, and rubella (MMR) vaccination | CDC. (n.d.).

MEASLES VACCINE | MSF Medical Guidelines. (n.d.).

Michael. (2023, April 5). Measles: Signs and symptoms - Commwellhealth.org.

Professional, C. C. M. (n.d.). Measles. Cleveland Clinic.